These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9546952)

  • 1. Role of endothelial cells in allograft rejection.
    Rose ML
    Vasc Med; 1997; 2(2):105-14. PubMed ID: 9546952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cells as antigen-presenting cells: role in human transplant rejection.
    Rose ML
    Cell Mol Life Sci; 1998 Sep; 54(9):965-78. PubMed ID: 9791539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the role of professional versus semiprofessional or nonprofessional antigen presenting cells in the rejection of vascularized organ allografts.
    Sundstrom JB; Ansari AA
    Transpl Immunol; 1995 Dec; 3(4):273-89. PubMed ID: 8665146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adhesion molecules (E-selectin and ICAM-1) in pulmonary allograft rejection.
    Shreeniwas R; Schulman LL; Narasimhan M; McGregor CC; Marboe CC
    Chest; 1996 Nov; 110(5):1143-9. PubMed ID: 8915211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-step model of acute CD4 T-cell mediated cardiac allograft rejection.
    Grazia TJ; Pietra BA; Johnson ZA; Kelly BP; Plenter RJ; Gill RG
    J Immunol; 2004 Jun; 172(12):7451-8. PubMed ID: 15187123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological function of the endothelial cell within the setting of organ transplantation.
    Taflin C; Charron D; Glotz D; Mooney N
    Immunol Lett; 2011 Sep; 139(1-2):1-6. PubMed ID: 21641935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.
    Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG
    J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelium does not activate CD4+ direct allorecognition in graft rejection.
    Kreisel D; Krasinskas AM; Krupnick AS; Gelman AE; Balsara KR; Popma SH; Riha M; Rosengard AM; Turka LA; Rosengard BR
    J Immunol; 2004 Sep; 173(5):3027-34. PubMed ID: 15322162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do endothelial cells fit the paradigm of antigen-presenting cells?
    Lechler RI; Marelli-Berg FM
    Biochem Soc Trans; 1997 May; 25(2):723-7. PubMed ID: 9191191
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of the graft endothelium in transplant rejection: evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection.
    Denton MD; Davis SF; Baum MA; Melter M; Reinders ME; Exeni A; Samsonov DV; Fang J; Ganz P; Briscoe DM
    Pediatr Transplant; 2000 Nov; 4(4):252-60. PubMed ID: 11079263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial activation and chronic allograft rejection.
    Orosz CG
    Clin Transplant; 1994 Jun; 8(3 Pt 2):299-303. PubMed ID: 7520304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The immune response to kidney allograft. Part I: the role of MHC antigens, antigen-presenting cells, and lymphocytes in alloantigen recognition; two-signal activation of T cells].
    Kusztal M; Jezior D; Weyde W; Krajewska M; Klinger M
    Postepy Hig Med Dosw (Online); 2007; 61():13-20. PubMed ID: 17245313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of vascular endothelial cells in transplantation.
    Sedmak DD; Orosz CG
    Arch Pathol Lab Med; 1991 Mar; 115(3):260-5. PubMed ID: 1848059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunobiology of rejection and adaptation.
    Trivedi HL
    Transplant Proc; 2007 Apr; 39(3):647-52. PubMed ID: 17445565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute rejection of orthotopic corneal xenografts in mice depends on CD4(+) T cells and self-antigen-presenting cells.
    Tanaka K; Sonoda K; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2878-84. PubMed ID: 11687532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation.
    Carter V; Shenton BK; Jaques B; Turner D; Talbot D; Gupta A; Chapman CE; Matthews CJ; Cavanagh G
    Transplant Proc; 2005 Mar; 37(2):654-7. PubMed ID: 15848491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
    Buonocore S; Flamand V; Goldman M; Braun MY
    Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.